Annals of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회지)

The Korean Association of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회)
권호 표지

Chronologic Change of Hyperinsulinemic Hypoglycemic Disease-insulinoma and Nesidioblastosis in 64 Patients

고인슐린혈증 저혈당증 질환의 연대기적 변화 -인슐린종과 췌도세포증 환자 64예

  • Lee, Jung-Woo (Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Kim, Song-Chael (Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Han, Duck-Jong (Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center)
  • 이정우 (울산대학교 의과대학 서울아산병원 외과학교실) ;
  • 김송철 (울산대학교 의과대학 서울아산병원 외과학교실) ;
  • 한덕종 (울산대학교 의과대학 서울아산병원 외과학교실)
  • Published : 2009.12.31

⟨ Previous Next ⟩

Abstract

Purpose: Insulinomas and nesidioblastosis are surgically curarable hyperinsulinemic hypoglycemic diseases; however the symptoms, diagnosis, and localization of these diseases are sometimes difficult. Methods: From April 1990 to December 2008, patients with diagnosis of pancreatic insulinoma and nesidioblastosis were retrospectively reviewed. Results: In the entire cohort, there were 6 patients with multiple endocrine neoplasia type 1 (MEN 1), 7 patients with nesidioblastosis, and 7 patients with multiple lesions. The incidence of neuroglycopenic symptoms (71.5%) was more prevalent than autonomic symptoms (26.5%). The pre-operative localization methods were computed tomography (CT), transabdominal ultrasonography, endoscopic ultrasonography (EUS), magnetic resonance imaging (MRI), angiography, selective arterial calcium stimulation with venous sampling (ASVS), and transhepatic portal venous sampling (THPVS) which had sensitivities of 75%, 40%, 75%, 64%, 48%, 20%, and 87%, respectively. During the second half of the study period, CT had a sensitivity of 83%. THPVS was the most sensitive method of all the diagnostic tools. Intra-operative palpation and ultrasonography were the most powerful modalities for tumor localization. The surgical treatments included enucleation (20%), distal pancreatectomy (51%), central pancreatectomy (12%), pancreaticoduodenectomy (15%), and near-total pancreatectomy (1.5%). From 2006, laparascopic surgery was used as the preferred treatment modality for insulinomas. Conclusion: Early diagnosis and precise localization is the most important aspect of treating insulinomas. For better localization, dual phase spiral CT and intra-operative ultrasonography play an important role in tumor localization.

Keywords

References

  1. Wilder RM, Allan FM, Power MH, Robertson HE. Carcinoma of the islets of the pancreas: hyperinsulinism and hypoglycemia. JAMA 1927;89:348-355. https://doi.org/10.1001/jama.1927.02690050014007
  2. Doherty GM, Doppman JL, Shawker TH, et al. Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery 1991;110:989-997.
  3. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66:711-719. https://doi.org/10.1016/S0025-6196(12)62083-7
  4. Kang CM, Park SH, Kim KS, Choi JS, Lee WJ, Kim BR. Surgical experiences of functioning neuroendocrine neoplasm of the pancreas. Yonsei Med J 2006;47:833-839. https://doi.org/10.3349/ymj.2006.47.6.833
  5. Kang YI, Yang BH, Chon S, et al. A case of malignant insulinoma metastasized to liver after partial pancreatectomy due to insulinoma 10 years before. J Korean Soc Endocrinol 2006;21:68-73. https://doi.org/10.3803/jkes.2006.21.1.68
  6. Lee SH, Kang CM, Kim JY, et al. Single institutional experiences of insulinoma. J Korean Surg Soc 2007;72:128-132
  7. Jung JP, Kim SC, Kim TH, Jang HJ, Han DJ. Islet cell tumors of the pancreas. J Korean Surg Soc 2000;58:840-850.
  8. Yoo YK, Park IY, Chin HM, et al. Insulinoma of the pancreas. J Korean Surg Soc 2003;64:498-504.
  9. Seo JH, Lee KS, Kim SJ, et al. Insulinoma of the pancreas. J Korean Surg Soc 1997;53:265-274.
  10. Jang HJ, Kim SC, Lee HK, et al. Surgically correctable hyperinsulinemic hypoglycemia in adults insulinoma vs. nesidioblastosis. J Korean Surg Soc 1998;55:757-768.
  11. Kim DK, Lee SD, Nam SJ, et al. Pancreatic islet cell tumor: clinical review of 12 cases. J Korean Surg Soc 1999;56:877- 885.
  12. Park HJ, Park JY, Shong YK, et al. Clinical manifestation of 16 cases with insulinoma or nesidioblastosis. Korean J Med 1999;56:189-195.
  13. Witteles RM, Straus II FH, Sugg SL, Koka MR, Costa EA, Kaplan EL. Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Arch Surg 2001;136:656-663. https://doi.org/10.1001/archsurg.136.6.656
  14. Harness JK, Geelhoed GW, Thompson NW, et al. Nesidioblastosis in adults. A surgical dilemma. Arch Surg 1981;116: 575-580. https://doi.org/10.1001/archsurg.1981.01380170055010
  15. Fong TL, Warner NE, Kumar D. Pancreatic nesidioblastosis in adults. Diabetes Care 1989;12:108-114. https://doi.org/10.2337/diacare.12.2.108
  16. Jaffe R, Hashida Y, Yunis EJ. Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 1980;42: 356-365.
  17. Virally M, Guillausseau P. Hypoglycemia in adults. Diabetes Metab 1999;25:477-490.
  18. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma- incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66:711-719. https://doi.org/10.1016/S0025-6196(12)62083-7
  19. Whipple AO, Frantz VK. Adenoma of islet cells with hyperinsulinism: a review. Ann Surg 1935;101:1299-1335. https://doi.org/10.1097/00000658-193506000-00001
  20. Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993;42:1791-1798. https://doi.org/10.2337/diabetes.42.12.1791
  21. Service F. Hypoglycemic disorders. N Engl J Med 1995;332: 1144-1152. https://doi.org/10.1056/NEJM199504273321707
  22. Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol 2005; 19:783-798. https://doi.org/10.1016/j.bpg.2005.05.008
  23. Hirshberg B, Livi A, Bartlett DL, et al. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 2000;85:3222-3226. https://doi.org/10.1210/jc.85.9.3222
  24. Finlayson E, Clark OH. Surgical treatment of insulinomas. Surg Clin North Am 2004;84:775-785. https://doi.org/10.1016/j.suc.2004.02.004
  25. Grant CS, van Heerden J, Charboneau JW, James EM, Reading CC. Insulinoma. The value of intraoperative ultrasonography. Arch Surg 1988;123:843-848. https://doi.org/10.1001/archsurg.1988.01400310057009
  26. Sotoudehmanesh R, Hedayat A, Shirazian N, et al. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 2007;31:238-241. https://doi.org/10.1007/s12020-007-0045-4
  27. Hammond PJ, Jackson JA, Bloom SR. Localization of pancreatic endocrine tumours. Clin Endocrinol (Oxf) 1994;40:3-14. https://doi.org/10.1111/j.1365-2265.1994.tb02436.x
  28. King AD, Ko GT, Yeung VT, Chow CC, Griffith J, Cockram CS. Dual phase spiral CT in the detection of small insulinomas of the pancreas. Br J Radiol 1998;71:20-23. https://doi.org/10.1259/bjr.71.841.9534694
  29. Fulton RE, Sheedy PF, McILRATH DC, Ferris DO. Preoperative angiographic localization of insulin-producing tumors of the pancreas. Am J Roentgenol Radium Ther Nucl Med 1975;123:367-377. https://doi.org/10.2214/ajr.123.2.367
  30. Brown CK, Bartlett DL, Doppman JL, et al. Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. Surgery 1997;122: 1189-1194. https://doi.org/10.1016/S0039-6060(97)90226-9